EyePoint (EYPT) Operating Expenses (2010 - 2026)
EyePoint (EYPT) reported Operating Expenses of $5.0 million for Q1 2026, up 10.3% on a YoY basis from $4.5 million in Q1 2025, and down 98.11% sequentially from $262.7 million in Q4 2025.
EyePoint (EYPT) Operating Expenses (2010 - 2026) Analysis & Trends
EyePoint (EYPT) has 17 years of Operating Expenses data on file, last reported at $5.0 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Expenses rose 10.3% year-over-year to $5.0 million; the trailing twelve-month figure through Mar 2026 stood at $339.3 million (up 396.0% YoY), and the FY2025 full-year result was $274.8 million, up 45.3% from the prior year.
- Operating Expenses eased to $5.0 million in Q1 2026, from $262.7 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $262.7 million in Q4 2025 to a low of -$72.5 million in Q4 2023.
- A 5-year average of $36.0 million and a median of $29.2 million in 2023 frame the typical range for Operating Expenses.
- Across the five-year window, Operating Expenses tumbled 233.65% in 2023 and jumped 1779.8% in 2025, its largest moves.
- Tracing EYPT's Operating Expenses over 5 years: stood at $54.3 million in 2022, then plunged by 233.65% to -$72.5 million in 2023, then surged by 178.35% to $56.8 million in 2024, then soared by 362.33% to $262.7 million in 2025, then slumped by 98.11% to $5.0 million in 2026.
- Business Quant data shows EYPT's Operating Expenses at $5.0 million in Q1 2026, $262.7 million in Q4 2025, and $4.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.10 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.78 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 2.89 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 445.22 Mn |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 | 4.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.96 Mn |
| Dec 31, 2025 | 262.73 Mn |
| Sep 30, 2025 | 4.01 Mn |
| Jun 30, 2025 | 67.56 Mn |
| Mar 31, 2025 | 4.50 Mn |
| Dec 31, 2024 | 56.83 Mn |
| Sep 30, 2024 | 3.48 Mn |
| Jun 30, 2024 | 3.59 Mn |
| Mar 31, 2024 | 45.01 Mn |
| Dec 31, 2023 | -72.53 Mn |
| Sep 30, 2023 | 29.60 Mn |
| Jun 30, 2023 | 31.87 Mn |
| Mar 31, 2023 | 29.24 Mn |
| Dec 31, 2022 | 54.27 Mn |
| Sep 30, 2022 | 28.41 Mn |
| Jun 30, 2022 | 30.78 Mn |
| Mar 31, 2022 | 27.58 Mn |
| Dec 31, 2021 | 29.59 Mn |
| Sep 30, 2021 | 24.37 Mn |
| Jun 30, 2021 | 19.99 Mn |